Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Management of facial erythema of rosacea: what is the role of topical α-adrenergic receptor agonist therapy?

Del Rosso JQ.

J Am Acad Dermatol. 2013 Dec;69(6 Suppl 1):S44-56. doi: 10.1016/j.jaad.2013.06.009.

PMID:
24229637
[PubMed - indexed for MEDLINE]
3.

Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.

Fowler J, Jarratt M, Moore A, Meadows K, Pollack A, Steinhoff M, Liu Y, Leoni M; Brimonidine Phase II Study Group.

Br J Dermatol. 2012 Mar;166(3):633-41. doi: 10.1111/j.1365-2133.2011.10716.x.

PMID:
22050040
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study.

Moore A, Kempers S, Murakawa G, Weiss J, Tauscher A, Swinyer L, Liu H, Leoni M.

J Drugs Dermatol. 2014 Jan;13(1):56-61.

PMID:
24385120
[PubMed - indexed for MEDLINE]
5.

Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.

Fowler J Jr, Jackson M, Moore A, Jarratt M, Jones T, Meadows K, Steinhoff M, Rudisill D, Leoni M.

J Drugs Dermatol. 2013 Jun 1;12(6):650-6.

PMID:
23839181
[PubMed - indexed for MEDLINE]
6.

Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline.

Shanler SD, Ondo AL.

Arch Dermatol. 2007 Nov;143(11):1369-71. No abstract available.

PMID:
18025359
[PubMed - indexed for MEDLINE]
8.

Rosacea: update on management and emerging therapies.

Fallen RS, Gooderham M.

Skin Therapy Lett. 2012 Dec;17(10):1-4.

PMID:
23223767
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

A review of the diagnosis and treatment of rosacea.

Scheinfeld N, Berk T.

Postgrad Med. 2010 Jan;122(1):139-43. doi: 10.3810/pgm.2010.01.2107. Review.

PMID:
20107297
[PubMed - indexed for MEDLINE]
11.

Topical metronidazole maintains remissions of rosacea.

Dahl MV, Katz HI, Krueger GG, Millikan LE, Odom RB, Parker F, Wolf JE Jr, Aly R, Bayles C, Reusser B, Weidner M, Coleman E, Patrignelli R, Tuley MR, Baker MO, Herndon JH Jr, Czernielewski JM.

Arch Dermatol. 1998 Jun;134(6):679-83.

PMID:
9645635
[PubMed - indexed for MEDLINE]
12.

Brimonidine effective but may lead to significant rebound erythema.

Ilkovitch D, Pomerantz RG.

J Am Acad Dermatol. 2014 May;70(5):e109-10. doi: 10.1016/j.jaad.2014.01.853. No abstract available.

PMID:
24742853
[PubMed - indexed for MEDLINE]
Free Article
13.

Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea.

Wolf JE Jr, Kerrouche N, Arsonnaud S.

Cutis. 2006 Apr;77(4 Suppl):3-11.

PMID:
16706244
[PubMed - indexed for MEDLINE]
14.

[Topical therapy of rosacea].

Schöfer H.

Hautarzt. 2013 Jul;64(7):494-9. doi: 10.1007/s00105-012-2518-5. German.

PMID:
23780475
[PubMed - indexed for MEDLINE]
15.

A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.

Elewski BE, Fleischer AB Jr, Pariser DM.

Arch Dermatol. 2003 Nov;139(11):1444-50.

PMID:
14623704
[PubMed - indexed for MEDLINE]
16.

Current drug therapies for rosacea: a chronic vascular and inflammatory skin disease.

Feldman SR, Huang WW, Huynh TT.

J Manag Care Pharm. 2014 Jun;20(6):623-9.

PMID:
24856600
[PubMed - in process]
Free Article
17.

Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea.

Tong LX, Moore AY.

Expert Rev Clin Pharmacol. 2014 Sep;7(5):567-77. doi: 10.1586/17512433.2014.945910. Epub 2014 Aug 4.

PMID:
25091290
[PubMed - in process]
18.

Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.

Dahl MV, Jarratt M, Kaplan D, Tuley MR, Baker MD.

J Am Acad Dermatol. 2001 Nov;45(5):723-30.

PMID:
11606923
[PubMed - indexed for MEDLINE]
19.

Rosacea treatments: What's new and what's on the horizon?

Gallo R, Drago F, Paolino S, Parodi A.

Am J Clin Dermatol. 2010;11(5):299-303. doi: 10.2165/11537020-000000000-00000.

PMID:
20642292
[PubMed - indexed for MEDLINE]
20.

[New possibilities in the treatment of early stages of rosacea].

Tsiskarishvili NV, Katsitadze A, Tsiskarishvili Ts.

Georgian Med News. 2013 Jan;(214):23-8. Russian.

PMID:
23388530
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk